Copyright Reports & Markets. All rights reserved.

Global Antipyretic Drugs for Children Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Antipyretic Drugs for Children Market Overview

    • 1.1 Product Overview and Scope of Antipyretic Drugs for Children
    • 1.2 Classification of Antipyretic Drugs for Children by Types
      • 1.2.1 Global Antipyretic Drugs for Children Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Antipyretic Drugs for Children Revenue Market Share by Types in 2018
      • 1.2.3 Paracetamol
      • 1.2.4 Aspirin
      • 1.2.5 Ibuprofen
      • 1.2.6 Noproxen
      • 1.2.7 Diclofenac
      • 1.2.8 Acetaminophen
    • 1.3 Global Antipyretic Drugs for Children Market by Application
      • 1.3.1 Global Antipyretic Drugs for Children Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Tablet Drug
      • 1.3.3 Granules Drug
      • 1.3.4 Oral Solution
      • 1.3.5 Others
    • 1.4 Global Antipyretic Drugs for Children Market by Regions
      • 1.4.1 Global Antipyretic Drugs for Children Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Antipyretic Drugs for Children Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Antipyretic Drugs for Children Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antipyretic Drugs for Children Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Antipyretic Drugs for Children Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antipyretic Drugs for Children Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Antipyretic Drugs for Children (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Mallinckrodt
      • 2.1.1 Business Overview
      • 2.1.2 Antipyretic Drugs for Children Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Mallinckrodt Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Anqiu Lu'an
      • 2.2.1 Business Overview
      • 2.2.2 Antipyretic Drugs for Children Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Anqiu Lu'an Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Granules India
      • 2.3.1 Business Overview
      • 2.3.2 Antipyretic Drugs for Children Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Granules India Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Zhejiang Kangle
      • 2.4.1 Business Overview
      • 2.4.2 Antipyretic Drugs for Children Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Zhejiang Kangle Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Farmson
      • 2.5.1 Business Overview
      • 2.5.2 Antipyretic Drugs for Children Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Farmson Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Hebei Jiheng
      • 2.6.1 Business Overview
      • 2.6.2 Antipyretic Drugs for Children Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Hebei Jiheng Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Novacyl
      • 2.7.1 Business Overview
      • 2.7.2 Antipyretic Drugs for Children Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Novacyl Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Anhui BBCA Likang
      • 2.8.1 Business Overview
      • 2.8.2 Antipyretic Drugs for Children Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Anhui BBCA Likang Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Anhui Fubore
      • 2.9.1 Business Overview
      • 2.9.2 Antipyretic Drugs for Children Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Anhui Fubore Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 SKPL
      • 2.10.1 Business Overview
      • 2.10.2 Antipyretic Drugs for Children Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 SKPL Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Atabay
      • 2.11.1 Business Overview
      • 2.11.2 Antipyretic Drugs for Children Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Atabay Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Huzhou Konch
      • 2.12.1 Business Overview
      • 2.12.2 Antipyretic Drugs for Children Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Huzhou Konch Antipyretic Drugs for Children Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Antipyretic Drugs for Children Market Competition, by Players

    • 3.1 Global Antipyretic Drugs for Children Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Antipyretic Drugs for Children Players Market Share
      • 3.2.2 Top 10 Antipyretic Drugs for Children Players Market Share
    • 3.3 Market Competition Trend

    4 Global Antipyretic Drugs for Children Market Size by Regions

    • 4.1 Global Antipyretic Drugs for Children Revenue and Market Share by Regions
    • 4.2 North America Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 4.5 South America Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)

    5 North America Antipyretic Drugs for Children Revenue by Countries

    • 5.1 North America Antipyretic Drugs for Children Revenue by Countries (2014-2019)
    • 5.2 USA Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)

    6 Europe Antipyretic Drugs for Children Revenue by Countries

    • 6.1 Europe Antipyretic Drugs for Children Revenue by Countries (2014-2019)
    • 6.2 Germany Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 6.3 UK Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 6.4 France Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Antipyretic Drugs for Children Revenue by Countries

    • 7.1 Asia-Pacific Antipyretic Drugs for Children Revenue by Countries (2014-2019)
    • 7.2 China Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 7.5 India Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)

    8 South America Antipyretic Drugs for Children Revenue by Countries

    • 8.1 South America Antipyretic Drugs for Children Revenue by Countries (2014-2019)
    • 8.2 Brazil Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Antipyretic Drugs for Children by Countries

    • 9.1 Middle East and Africa Antipyretic Drugs for Children Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Antipyretic Drugs for Children Revenue and Growth Rate (2014-2019)

    10 Global Antipyretic Drugs for Children Market Segment by Type

    • 10.1 Global Antipyretic Drugs for Children Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Antipyretic Drugs for Children Market Forecast by Type (2019-2024)
    • 10.3 Paracetamol Revenue Growth Rate (2014-2024)
    • 10.4 Aspirin Revenue Growth Rate (2014-2024)
    • 10.5 Ibuprofen Revenue Growth Rate (2014-2024)
    • 10.6 Noproxen Revenue Growth Rate (2014-2024)
    • 10.7 Diclofenac Revenue Growth Rate (2014-2024)
    • 10.8 Acetaminophen Revenue Growth Rate (2014-2024)

    11 Global Antipyretic Drugs for Children Market Segment by Application

    • 11.1 Global Antipyretic Drugs for Children Revenue Market Share by Application (2014-2019)
    • 11.2 Antipyretic Drugs for Children Market Forecast by Application (2019-2024)
    • 11.3 Tablet Drug Revenue Growth (2014-2019)
    • 11.4 Granules Drug Revenue Growth (2014-2019)
    • 11.5 Oral Solution Revenue Growth (2014-2019)
    • 11.6 Others Revenue Growth (2014-2019)

    12 Global Antipyretic Drugs for Children Market Size Forecast (2019-2024)

    • 12.1 Global Antipyretic Drugs for Children Market Size Forecast (2019-2024)
    • 12.2 Global Antipyretic Drugs for Children Market Forecast by Regions (2019-2024)
    • 12.3 North America Antipyretic Drugs for Children Revenue Market Forecast (2019-2024)
    • 12.4 Europe Antipyretic Drugs for Children Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Antipyretic Drugs for Children Revenue Market Forecast (2019-2024)
    • 12.6 South America Antipyretic Drugs for Children Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Antipyretic Drugs for Children Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Antipyretic Drugs for Children are the drugs which are essentially help to reduce the elevated temperature to normal temperature i.e 37.

      Scope of the Report:
      The global Antipyretic Drugs for Children market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antipyretic Drugs for Children.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Antipyretic Drugs for Children market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antipyretic Drugs for Children market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Mallinckrodt
      Anqiu Lu'an
      Granules India
      Zhejiang Kangle
      Farmson
      Hebei Jiheng
      Novacyl
      Anhui BBCA Likang
      Anhui Fubore
      SKPL
      Atabay
      Huzhou Konch

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Paracetamol
      Aspirin
      Ibuprofen
      Noproxen
      Diclofenac
      Acetaminophen

      Market Segment by Applications, can be divided into
      Tablet Drug
      Granules Drug
      Oral Solution
      Others

      Buy now